Does Valium Help With Pain? A Scientific Look

Valium (diazepam) is not a painkiller in the traditional sense, and the evidence that it directly reduces pain is surprisingly thin. Diazepam is a benzodiazepine, a class of drugs designed to treat anxiety, seizures, and muscle spasms. Doctors sometimes prescribe it alongside pain conditions, but the reasons have more to do with relaxing muscles and calming anxiety than with blocking pain signals. The story gets more interesting when you look at how pain, anxiety, and muscle tension interact, and why a drug that seems to help in some situations shows no benefit at all in others.

What Diazepam Actually Does

Diazepam works by boosting the activity of a chemical messenger in the brain and spinal cord called GABA, which slows down nerve signaling. This produces the familiar calming, sedating, and muscle-relaxing effects. Animal research has long confirmed that diazepam depresses certain spinal reflexes and can abolish the kind of rigid muscle tone seen in experimental models, which is part of why it earned a reputation as a muscle relaxant decades ago.¹ But relaxing a tense muscle and relieving pain are two different things, and the jump from one to the other is where much of the confusion lives.

Classical benzodiazepines like diazepam do strengthen inhibitory circuits in the spinal cord that help control pain signals. The problem is that at the doses needed to meaningfully affect those circuits, sedation becomes the limiting factor. You get sleepy before you get pain relief. Research in genetically engineered mice has shown that if you could somehow strip away the sedation, the underlying pain-dampening potential of these drugs is substantial. But with currently available benzodiazepines, that sedation ceiling keeps genuine analgesic activity out of clinical reach.²

Acute Low Back Pain and the Emergency Room Evidence

Low back pain is the condition most often studied in connection with diazepam and pain relief, partly because muscle spasm frequently accompanies it and partly because Valium is still prescribed for it in emergency departments. The results, however, are mixed at best.

One randomized trial in an emergency department compared diazepam head-to-head with methocarbamol (another muscle relaxant) for acute low back pain. Both drugs reduced pain scores after an hour, with diazepam performing slightly better in terms of raw pain reduction on a visual scale.³ That sounds promising until you look at the bigger picture. A separate, well-designed trial gave emergency department patients with acute low back pain either naproxen plus diazepam or naproxen plus a placebo. One week later, both groups had improved by the same amount, and the difference between them was neither clinically meaningful nor statistically significant. The same held true at three months.⁴

That second result is important because it reflects how most people actually experience low back pain treatment: they are already taking an anti-inflammatory drug, and the question is whether adding Valium on top of it does anything extra. The answer, at least for the common non-traumatic, non-nerve-related type of back pain, appears to be no.

The American College of Physicians clinical practice guideline for low back pain recommends that if you want medication for acute or subacute back pain, the first-line options are anti-inflammatory drugs or skeletal muscle relaxants, with the understanding that most episodes improve on their own regardless of treatment.⁵ Diazepam technically falls under the muscle relaxant umbrella, but the guideline does not single it out as a preferred choice. A systematic review supporting that guideline noted that while benzodiazepines showed some evidence of pain relief in certain trials, they were ineffective for radiculopathy, the type of back pain that shoots down the leg due to nerve compression.⁶

Chronic Pain and the Case Against Long-Term Use

If the evidence for Valium in acute pain is underwhelming, the evidence for chronic pain is even weaker. A narrative review examining benzodiazepines across more than a hundred different pain conditions found that the research was too sparse, too varied, and too small to draw firm conclusions about whether these drugs help with the vast majority of chronic pain states. The review did note that benzodiazepines could be useful for co-occurring insomnia or anxiety disorders in pain patients, but only when other treatments had failed and only for short durations of two to four weeks.⁷

A major reason for that short time limit is tolerance. Benzodiazepines lose their effectiveness with continued use, and physical dependence develops in a large proportion of people who take them for more than a month. This creates a painful irony: the drug stops working for whatever it was prescribed for, but stopping it produces its own set of problems, including rebound anxiety, insomnia, and sometimes increased pain sensitivity.⁸

Meanwhile, the underlying science of chronic pain has revealed something intriguing. In many chronic pain states, the spinal cord’s natural GABA-based inhibition breaks down. Inflammation or nerve damage can weaken these inhibitory circuits, leading to heightened pain sensitivity and even pain from stimuli that should not hurt at all.⁹ In theory, a drug that boosts GABA activity should restore that lost braking system. But classical benzodiazepines are too blunt an instrument: they hit all the GABA receptor subtypes at once, producing sedation alongside any pain-dampening effect.

Why Valium Changes How Pain Feels Without Changing the Pain Itself

One of the more interesting findings in this area is that diazepam appears to alter the emotional dimension of pain rather than the raw sensation. In a study using experimental pain in human volunteers, diazepam significantly lowered participants’ responses on emotional pain descriptors (the “how distressing” aspect) without changing their sensory responses (the “how intense” aspect).¹⁰ In other words, people still felt the same physical sensation, but it bothered them less.

Animal research supports this pattern. When diazepam was injected into specific brain regions involved in both fear and pain processing, it simultaneously reduced anxiety-like behavior and increased pain tolerance. The two effects were correlated, suggesting that calming the emotional alarm system made pain more bearable.¹¹

This distinction matters in real life. If your pain is amplified by anxiety, poor sleep, or muscle tension, diazepam’s ability to ease those amplifiers might make the pain feel more manageable even though the underlying pain generator has not changed. But calling that “pain relief” stretches the definition. It helps explain why some patients insist Valium helps their pain while clinical trials keep failing to show a benefit: the drug is changing their relationship to the pain, not the pain signal itself.

Where Diazepam Genuinely Helps With Pain-Related Conditions

There are a few specific clinical scenarios where diazepam has earned a legitimate role, though even these come with caveats.

Spasticity from neurological conditions is the most established use case. In people with spinal cord injuries, diazepam is considered effective for reducing the painful, involuntary muscle tightness that can develop after damage to the central nervous system.¹² In children with cerebral palsy, a controlled trial found that roughly a third of participants achieved excellent muscle relaxation on diazepam with no corresponding improvement on placebo. Children with the athetoid form of cerebral palsy (characterized by involuntary writhing movements) responded better than those with spastic-type cerebral palsy.¹³ A more recent trial showed measurable improvement in spasticity scores over three months of oral diazepam, though drowsiness was the most common side effect.¹⁴ A recent clinical guideline acknowledges that long-term benzodiazepine use may be appropriate specifically for medical conditions like spasticity and certain movement-related sleep disorders, even when long-term use is otherwise discouraged.¹⁵

Pelvic floor pain is a condition where vaginal diazepam has been tried, on the theory that the pelvic floor muscles are in a state of sustained, painful contraction that diazepam might release. The results have been disappointing. A randomized placebo-controlled trial of nightly vaginal diazepam over four weeks found no improvement in muscle activity or symptoms compared with placebo.¹⁶ A systematic review and meta-analysis echoed this conclusion: no statistically significant differences between diazepam and placebo groups, with both showing only minor, non-significant improvements in pain.¹⁷ Despite its continued use in some clinics, the evidence does not support vaginal diazepam as a standalone treatment for this condition.

How Valium Compares to Other Muscle Relaxants

If you are prescribed a muscle relaxant for pain, diazepam is not the only option, and it may not be the best one. Cyclobenzaprine (Flexeril) is the most commonly prescribed non-benzodiazepine muscle relaxant in the United States. In a double-blind trial comparing cyclobenzaprine, diazepam, and placebo for neck and low back spasm, all three groups improved over two weeks, but cyclobenzaprine was statistically preferred over diazepam.¹⁸ Cyclobenzaprine carries its own sedation burden and is not without side effects, but it does not carry the same dependence risk as benzodiazepines.¹⁹

Baclofen is another common alternative, particularly for neurological spasticity. It works on a different type of GABA receptor and tends to produce less of the cognitive blunting that diazepam causes. For someone whose pain is driven by spasticity, the choice between diazepam and baclofen often comes down to individual response and side-effect tolerance rather than one being clearly superior to the other.

The Danger of Combining Valium With Opioids

Perhaps the most important practical issue around Valium and pain involves what happens when it is prescribed alongside opioid painkillers. This combination is more common than you might expect, and it is dangerous. A large cohort study tracking nearly 21,000 patients found that co-prescribing benzodiazepines with opioid agonist therapy raised the risk of non-fatal overdose requiring hospitalization by roughly 45%.²⁰ Both drug classes suppress breathing, and together they can push respiratory depression to a life-threatening level.

The FDA added a black-box warning to both benzodiazepines and opioids about this combination in 2016, and prescribing guidelines have tightened considerably since then. If you are already taking an opioid for pain and a doctor suggests adding Valium, or vice versa, the conversation should include an explicit discussion of this risk.

Withdrawal Can Make Pain Worse

Anyone who has taken diazepam regularly for more than a few weeks should know that stopping abruptly can produce a withdrawal syndrome that includes, among other things, muscular pain and stiffness, headaches, and heightened sensitivity to sensory stimuli.⁸ The most common withdrawal effects are rebound anxiety and insomnia, appearing within one to four days after the last dose depending on how long the drug stays in the body. Diazepam is a long-acting benzodiazepine, so withdrawal tends to come on more gradually than with shorter-acting drugs like alprazolam (Xanax), but it can still be significant.

This creates a trap for pain patients. They start diazepam for muscle spasm or anxiety related to pain, develop tolerance over weeks, and then find that reducing the dose brings back their pain with a vengeance, sometimes worse than before. That worsening is partly withdrawal, not the original condition returning, but it can be difficult to tell the difference from the inside. Gradual tapering under medical supervision is the recommended approach for anyone who has been on benzodiazepines for more than a few weeks.

The Future of GABA-Targeting Pain Drugs

The science behind diazepam’s mixed track record has actually opened up one of the more promising avenues in pain research. The key insight is that not all GABA receptors are the same. The sedation that limits classical benzodiazepines is driven primarily by one receptor subtype (containing the alpha-1 subunit), while pain-dampening effects appear to flow mainly through a different subtype (containing the alpha-2 subunit). If you could design a drug that selectively activates the pain-relevant subtype while leaving the sedation-causing one alone, you might get meaningful pain relief without the drowsiness, cognitive fog, or dependence risk that makes long-term benzodiazepine use problematic.²

This is not purely theoretical. Proof-of-concept studies in human volunteers have demonstrated that drugs acting on GABA receptors can reduce central sensitization, the process by which the nervous system amplifies pain signals in chronic pain states.²¹ Researchers have also been exploring drugs that target different GABA receptor configurations altogether, specifically those found outside the synapses in spinal pain pathways, which appear to reduce pain behavior in animal models without the classical benzodiazepine side-effect profile.²²

None of these next-generation compounds have reached your pharmacy shelf yet, and the road from animal models to approved medications is long and littered with failures. But the direction of travel is clear: the GABA system is genuinely involved in pain processing, and a more precise drug could unlock that potential without the baggage that makes prescribing Valium for pain such a fraught decision today. The limitation was never the target; it was always the tool.